Biobridge: An Outlook on Translational Bioinks for 3D Bioprinting.
immunomodulation
instructive bioinks
organotypic vasculature
proregenerative bioinks
standardization
Journal
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
ISSN: 2198-3844
Titre abrégé: Adv Sci (Weinh)
Pays: Germany
ID NLM: 101664569
Informations de publication
Date de publication:
01 2022
01 2022
Historique:
revised:
20
10
2021
received:
09
08
2021
pubmed:
5
12
2021
medline:
24
3
2022
entrez:
4
12
2021
Statut:
ppublish
Résumé
3D-bioprinting (3DBP) possesses several elements necessary to overcome the deficiencies of conventional tissue engineering, such as defining tissue shape a priori, and serves as a bridge to clinical translation. This transformative potential of 3DBP hinges on the development of the next generation of bioinks that possess attributes for clinical use. Toward this end, in addition to physicochemical characteristics essential for printing, bioinks need to possess proregenerative attributes, while enabling printing of stable structures with a defined biological function that survives implantation and evolves in vivo into functional tissue. With a focus on bioinks for extrusion-based bioprinting, this perspective review advocates a rigorous biology-based approach to engineering bioinks, emphasizing efficiency, reproducibility, and a streamlined translation process that places the clinical endpoint front and center. A blueprint for engineering the next generation of bioinks that satisfy the aforementioned performance criteria for various translational levels (TRL1-5) and a characterization tool kit is presented.
Identifiants
pubmed: 34862764
doi: 10.1002/advs.202103469
pmc: PMC8787414
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2103469Subventions
Organisme : China Scholarship Council
Organisme : Deutsche Forschungsgemeinschaft
ID : (EXC 294)
Informations de copyright
© 2021 The Authors. Advanced Science published by Wiley-VCH GmbH.
Références
Adv Mater. 2019 May;31(21):e1808050
pubmed: 30924979
Acta Biomater. 2017 Jul 15;57:26-46
pubmed: 28501712
Sci Rep. 2016 Jun 27;6:28714
pubmed: 27346373
Biomater Res. 2019 Feb 06;23:3
pubmed: 30774971
Cell. 2009 Nov 25;139(5):891-906
pubmed: 19931152
ACS Biomater Sci Eng. 2018 Oct 8;4(10):3610-3616
pubmed: 33450800
Biomaterials. 2019 Nov;220:119403
pubmed: 31401468
Adv Mater. 2017 Aug;29(29):
pubmed: 28556553
Am J Pathol. 2015 Oct;185(10):2596-606
pubmed: 26118749
Adv Drug Deliv Rev. 2018 Jul;132:296-332
pubmed: 29990578
3D Print Addit Manuf. 2019 Jun;6(3):158-164
pubmed: 31860224
Front Pharmacol. 2021 Mar 11;12:581645
pubmed: 33776759
Cell. 2019 Oct 3;179(2):340-354
pubmed: 31585078
ACS Appl Bio Mater. 2019 Feb 18;2(2):796-806
pubmed: 35016284
Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3418-23
pubmed: 20133690
Nat Biotechnol. 2005 Jan;23(1):47-55
pubmed: 15637621
Adv Drug Deliv Rev. 2017 Dec 1;122:74-83
pubmed: 28526591
Adv Sci (Weinh). 2022 Jan;9(3):e2103469
pubmed: 34862764
Bioengineering (Basel). 2020 Nov 07;7(4):
pubmed: 33171883
Biomacromolecules. 2020 Oct 12;21(10):3997-4007
pubmed: 32841006
Mater Sci Eng C Mater Biol Appl. 2018 Feb 1;83:195-201
pubmed: 29208279
J Tissue Eng. 2021 Jul 29;12:20417314211027677
pubmed: 34377431
Mater Sci Eng C Mater Biol Appl. 2019 Jun;99:103-111
pubmed: 30889635
Exp Eye Res. 2018 Aug;173:188-193
pubmed: 29772228
Immunity. 2018 Oct 16;49(4):666-677.e6
pubmed: 30291029
Adv Healthc Mater. 2018 Mar;7(6):e1701026
pubmed: 29292585
Adv Mater. 2014 May 21;26(19):3124-30
pubmed: 24550124
Sci Rep. 2016 Nov 21;6:36928
pubmed: 27869206
Biomaterials. 2014 Jul;35(21):5453-61
pubmed: 24726536
Cytokine. 2016 Sep;85:123-9
pubmed: 27337694
Science. 2002 Feb 8;295(5557):1009-14
pubmed: 11834815
J Mater Sci Mater Med. 2019 Oct 19;30(10):120
pubmed: 31630272
J Biomater Appl. 2018 Nov;33(5):609-618
pubmed: 30360677
Adv Healthc Mater. 2017 Feb;6(4):
pubmed: 27976537
Biofabrication. 2017 Jun 26;9(2):024105
pubmed: 28569243
Annu Rev Biomed Eng. 2015;17:317-49
pubmed: 26421896
J Infect Public Health. 2011 Aug;4(3):108-24
pubmed: 21843857
Biofabrication. 2018 Nov 23;11(1):013001
pubmed: 30468151
Biochemistry (Mosc). 2014 Nov;79(11):1202-10
pubmed: 25540005
Methods Mol Biol. 2018;1758:129-138
pubmed: 29679327
Crit Rev Oncol Hematol. 2002 Jul;43(1):33-56
pubmed: 12098606
Adv Healthc Mater. 2017 Oct;6(20):
pubmed: 28731220
Science. 2019 May 3;364(6439):458-464
pubmed: 31048486
J Biomed Mater Res. 2002 May;60(2):217-23
pubmed: 11857427
Biofabrication. 2015 Nov 02;7(4):045002
pubmed: 26523399
Front Pharmacol. 2015 Sep 02;6:184
pubmed: 26388774
J Biomater Appl. 2016 Nov;31(5):684-692
pubmed: 27638155
Stem Cells Int. 2018 Dec 24;2018:3753547
pubmed: 30675168
Int Immunol. 2015 Mar;27(3):131-41
pubmed: 25267883
Nat Rev Immunol. 2011 Sep 23;11(10):702-11
pubmed: 21941296
Methods Mol Biol. 2017;1612:381-390
pubmed: 28634957
Nat Biotechnol. 2013 Jun;31(6):553-6
pubmed: 23666011
Nat Rev Mol Cell Biol. 2009 Jan;10(1):75-82
pubmed: 19197334
Proc Natl Acad Sci U S A. 2018 Jul 3;115(27):E6135-E6144
pubmed: 29915064
Adv Healthc Mater. 2016 Oct;5(19):2488-2492
pubmed: 27581767
Proc Natl Acad Sci U S A. 2005 Aug 9;102(32):11450-5
pubmed: 16055556
Biomed Mater. 2020 Oct 03;15(6):065017
pubmed: 32640427
J Mater Chem B. 2014 Apr 28;2(16):2282-2289
pubmed: 32261716
Nature. 2014 Mar 20;507(7492):323-328
pubmed: 24646994
Biotechnol Bioeng. 2009 Jul 1;103(4):655-63
pubmed: 19472329
Front Immunol. 2014 Nov 04;5:510
pubmed: 25408693
Science. 2019 Aug 2;365(6452):482-487
pubmed: 31371612
3 Biotech. 2016 Jun;6(1):67
pubmed: 28330137
Cell. 2006 Aug 25;126(4):677-89
pubmed: 16923388
Ann Biomed Eng. 2017 Jan;45(1):210-223
pubmed: 27503606
Macromol Biosci. 2006 Aug 7;6(8):623-33
pubmed: 16881042
Biofabrication. 2019 Apr 03;11(3):035003
pubmed: 30818298
Tissue Eng Part A. 2010 Aug;16(8):2675-85
pubmed: 20387987
Biomater Sci. 2019 Feb 26;7(3):1179-1187
pubmed: 30656307
Macromol Biosci. 2013 May;13(5):551-61
pubmed: 23420700
ACS Appl Mater Interfaces. 2020 Oct 7;12(40):44563-44577
pubmed: 32966746
Biomaterials. 2010 Aug;31(24):6173-81
pubmed: 20546891
Proc Natl Acad Sci U S A. 2014 Nov 11;111(45):16124-9
pubmed: 25349433
Langmuir. 2011 May 3;27(9):5204-10
pubmed: 21469673
Adv Healthc Mater. 2016 Feb 4;5(3):326-33
pubmed: 26626828
Cytotherapy. 2018 Jun;20(6):769-778
pubmed: 29730080
Nat Commun. 2017 May 16;8:15261
pubmed: 28509899
Biomaterials. 2011 Oct;32(28):6692-709
pubmed: 21715002
Adv Sci (Weinh). 2020 Jul 19;7(18):2001419
pubmed: 32999847
Oral Surg Oral Med Oral Pathol Oral Radiol. 2014 Jan;117(1):105-10
pubmed: 24332334
Sci Adv. 2015 Oct 23;1(9):e1500758
pubmed: 26601312
Biomater Sci. 2013 Feb 3;1(2):224-230
pubmed: 32481802
Biomaterials. 2014 Jan;35(1):49-62
pubmed: 24112804
Front Immunol. 2018 Mar 23;9:585
pubmed: 29662491
Biomaterials. 2015 Aug;61:203-15
pubmed: 26004235
Sci Adv. 2020 Sep 18;6(38):
pubmed: 32948593
Clin Cancer Res. 2019 Sep 15;25(18):5449-5457
pubmed: 30944124
Proc Natl Acad Sci U S A. 2013 Aug 6;110(32):12887-92
pubmed: 23886665
J Biomed Mater Res B Appl Biomater. 2003 Jul 15;66(1):347-55
pubmed: 12808594
Stem Cell Rev Rep. 2021 Aug;17(4):1239-1250
pubmed: 33454852
J R Soc Interface. 2006 Oct 22;3(10):589-601
pubmed: 16971328
Arch Plast Surg. 2015 Mar;42(2):232-9
pubmed: 25798398
Autoimmun Rev. 2011 Jan;10(3):175-9
pubmed: 20923710
Nature. 2016 Jan 21;529(7586):316-25
pubmed: 26791722
Exp Cell Res. 2021 Jan 1;398(1):112398
pubmed: 33271129
ACS Appl Mater Interfaces. 2020 May 6;12(18):20295-20306
pubmed: 32274920
ACS Nano. 2015 Mar 24;9(3):3109-18
pubmed: 25674809
Cell Calcium. 1998 Feb-Mar;23(2-3):173-80
pubmed: 9601613
Adv Mater. 2015 Mar 4;27(9):1607-14
pubmed: 25641220
Acta Biomater. 2020 Apr 1;106:114-123
pubmed: 32027992
Adv Healthc Mater. 2016 Jul;5(14):1724-30
pubmed: 27125336
Nat Commun. 2019 Oct 4;10(1):4509
pubmed: 31586055